"10.1371_journal.pone.0125519","plos one","2015-05-04T00:00:00Z","Masahiro Takihata; Akinobu Nakamura; Yoshinobu Kondo; Satsuki Kawasaki; Mari Kimura; Yasuo Terauchi","Department of Endocrinology and Metabolism, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan; Department of Endocrinology and Metabolism, Chigasaki Municipal Hospital, Chigasaki, Kanagawa, Japan; Department of Endocrinology and Metabolism, Shonan Fujisawa Tokushukai Hospital, Fujisawa, Kanagawa, Japan","Conceived and designed the experiments: MT AN YT. Performed the experiments: MT AN YK SK MK YT. Analyzed the data: MT. Contributed reagents/materials/analysis tools: MT AN YK SK MK YT. Wrote the paper: MT AN YT.","M.T. received honoraria for lectures from MSD, Ono Pharmaceutical Co. Ltd., Novartis Pharma, Takeda Pharmaceutical Company Ltd., Kowa Pharmaceutical Co., Ltd., Novo Nordisk Pharma Ltd., Eli Lilly and Company, Sanofi, Shionogi & Co., Ltd., and Kissei. A.N. received honoraria for lectures from MSD, Novartis Pharma, Takeda Pharmaceutical Company Ltd., Tanabe-Mitsubishi Pharma, Daiichi-Sankyo Company Ltd., Kowa Pharmaceutical Co., Ltd., Novo Nordisk Pharma Ltd., Eli Lilly and Company, Sanofi, DaiNippon-Sumitomo, Kissei, Phizer, and Astra Zeneca. Y.K. received honoraria for lectures from MSD, Takeda Pharmaceutical Company Ltd., Novo Nordisk Pharma Ltd., Eli Lilly and Company, Sanofi, and Bayer Yakuhin Ltd. S.K. received honoraria for lectures from Takeda Pharmaceutical Company Ltd. and Sanofi. M.K. received honoraria for lectures from Takeda Pharmaceutical Company Ltd., Eli Lilly and Company, and Sanofi. Y.T. received honoraria for lectures from MSD, Ono Pharmaceutical Co. Ltd., Boehringer Ingelheim GmbH, Novartis Pharma, Takeda Pharmaceutical Company Ltd., Tanabe-Mitsubishi Pharma, Daiichi-Sankyo Company Ltd., Sanwa Kagaku Kenkyusho Co., Ltd., Kowa Pharmaceutical Co., Ltd., Novo Nordisk Pharma Ltd., Eli Lilly and Company, Sanofi, DaiNippon-Sumitomo, Shionogi & Co., Ltd., Kissei, Bayer Yakuhin Ltd., Astellas Pharma Inc., Phizer, Astra Zeneca, Chugai Pharmaceutical Co., Ltd., Teijin, Mochida Pharmaceutical Co. Ltd., Roche Diagnostics and Johnson & Johnson. Y.T. received unrestricted grants from MSD, Ono Pharmaceutical Co. Ltd., Boehringer Ingelheim GmbH, Novartis Pharma, Takeda Pharmaceutical Company Ltd., Tanabe-Mitsubishi Pharma, Daiichi-Sankyo Company Ltd., Sanwa Kagaku Kenkyusho Co., Ltd., Kowa Pharmaceutical Co., Ltd., Novo Nordisk Pharma Ltd., Eli Lilly and Company, Sanofi, DaiNippon-Sumitomo, Shionogi & Co., Ltd., Kissei, Bayer Yakuhin Ltd., and Astellas Pharma Inc. The authors have no relationship with companies that might have an interest in the submitted work and they have no non-financial interests that may be relevant to the submitted work. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2015","05","Masahiro Takihata","MT",6,TRUE,3,6,1,3,TRUE,TRUE,FALSE,0,NA,FALSE
